Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Frontiers in Oncology
|
August 19, 2022
Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study
Sander Ellegård, Kristina Engvall, Mustafa Asowed, et al.
Biochemical and Biophysical Research Communications
|
January 26, 2010
The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells
Cecilia Trinks, Emelie A Djerf, Anna-Lotta Hallbeck, et al.
Lakartidningen
|
May 27, 2014
[Questionable effect of antiviral therapy in malignant brain tumors]
Sara Kinhult, Katja Werlenius, Anna-Lotta Hallbeck, et al.
Lakartidningen
|
August 28, 2014
[Inconclusive data]
Sara Kinhult, Katja Werlenius, Anna-Lotta Hallbeck, et al.
Oncotarget
|
April 28, 2015
Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death
Jaganmohan R Jangamreddy, Mayur V Jain, Anna-Lotta Hallbeck, et al.
Melanoma Research
|
May 13, 2009
ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)
Emelie A Djerf, Cecilia Trinks, Avni Abdiu, et al.
Genes, Chromosomes & Cancer
|
July 13, 2011
High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1
Elin Karlsson, Marie Ahnström Waltersson, Josefine Bostner, et al.
Plos One
|
December 25, 2015
Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis
Elin Karlsson, Ivana Magić, Josefine Bostner, et al.
Biochemical and Biophysical Research Communications
|
October 11, 2011
The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo
Emelie A Djerf Severinsson, Cecilia Trinks, Henrik Gréen, et al.
Biochemical and Biophysical Research Communications
|
June 15, 2011
The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells
Cecilia Trinks, Emelie A Severinsson, Birgitta Holmlund, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Frontiers in Oncology
|
August 19, 2022
Long-term follow-up of early stage HER2-positive breast cancer patients treated with trastuzumab: A population-based real world multicenter cohort study
Sander Ellegård, Kristina Engvall, Mustafa Asowed, et al.
Biochemical and Biophysical Research Communications
|
January 26, 2010
The pan-ErbB receptor tyrosine kinase inhibitor canertinib induces ErbB-independent apoptosis in human leukemia (HL-60 and U-937) cells
Cecilia Trinks, Emelie A Djerf, Anna-Lotta Hallbeck, et al.
Lakartidningen
|
May 27, 2014
[Questionable effect of antiviral therapy in malignant brain tumors]
Sara Kinhult, Katja Werlenius, Anna-Lotta Hallbeck, et al.
Lakartidningen
|
August 28, 2014
[Inconclusive data]
Sara Kinhult, Katja Werlenius, Anna-Lotta Hallbeck, et al.
Oncotarget
|
April 28, 2015
Glucose starvation-mediated inhibition of salinomycin induced autophagy amplifies cancer cell specific cell death
Jaganmohan R Jangamreddy, Mayur V Jain, Anna-Lotta Hallbeck, et al.
Melanoma Research
|
May 13, 2009
ErbB receptor tyrosine kinases contribute to proliferation of malignant melanoma cells: inhibition by gefitinib (ZD1839)
Emelie A Djerf, Cecilia Trinks, Avni Abdiu, et al.
Genes, Chromosomes & Cancer
|
July 13, 2011
High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1
Elin Karlsson, Marie Ahnström Waltersson, Josefine Bostner, et al.
Plos One
|
December 25, 2015
Revealing Different Roles of the mTOR-Targets S6K1 and S6K2 in Breast Cancer by Expression Profiling and Structural Analysis
Elin Karlsson, Ivana Magić, Josefine Bostner, et al.
Biochemical and Biophysical Research Communications
|
October 11, 2011
The pan-ErbB receptor tyrosine kinase inhibitor canertinib promotes apoptosis of malignant melanoma in vitro and displays anti-tumor activity in vivo
Emelie A Djerf Severinsson, Cecilia Trinks, Henrik Gréen, et al.
Biochemical and Biophysical Research Communications
|
June 15, 2011
The pan-ErbB tyrosine kinase inhibitor canertinib induces caspase-mediated cell death in human T-cell leukemia (Jurkat) cells
Cecilia Trinks, Emelie A Severinsson, Birgitta Holmlund, et al.
Page
of 2